Cyclacel Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2025 | 12.17 K | $58.66 K | 100.00% | 0.14% |
| UBS GROUP AG | 05/13/2025 | 5.38 K | $25.17 K | 6,302.38% | 0.06% |
| 05/06/2025 | 2.78 K | $13.00 K | 100.00% | 0.03% | |
| SOUND INCOME STRATEGIES, LLC | 04/17/2025 | 94 | $440 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclacel Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals, Inc.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 12,171
UBS Group AG: 5,378
Sound Income Strategies, LLC: 94
UBS AG: 0
0.23% of Cyclacel Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.64 K shares in the last 24 months. This purchase volume represents approximately $93.33 K in transactions.